Cargando…

Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy

The cancer testis antigen (CTA) lactate dehydrogenase C (LDHC) is a promising anticancer target with tumor‐specific expression and immunogenicity. Interrogation of breast cancer patient cohorts from The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (META...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naik, Adviti, Decock, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847988/ https://www.ncbi.nlm.nih.gov/pubmed/34050611 http://dx.doi.org/10.1002/1878-0261.13024

Ejemplares similares

Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
por: Thomas, Remy, et al.
Publicado: (2020)

Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors
por: Naik, Adviti, et al.
Publicado: (2020)

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
por: Naik, Adviti, et al.
Publicado: (2022)

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
por: Naik, Adviti, et al.
Publicado: (2019)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
por: Naik, Adviti, et al.
Publicado: (2021)

Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
por: Naik, A., et al.
Publicado: (2023)

Modulation of SLFN11 induces changes in DNA Damage response in breast cancer
por: Raynaud, Christophe Michel, et al.
Publicado: (2023)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
por: Al-Khadairi, Ghaneya, et al.
Publicado: (2019)

Transcription Factors: The Fulcrum Between Cell Development and Carcinogenesis
por: Islam, Zeyaul, et al.
Publicado: (2021)

Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
por: Zhou, Ming, et al.
Publicado: (2010)

Pyruvate dehydrogenase complex and lactate dehydrogenase are targets for therapy of acute liver failure
por: Ferriero, Rosa, et al.
Publicado: (2018)

TEMPORAL ORDER IN MAMMALIAN CELLS : I. The Periodic Synthesis of Lactate Dehydrogenase in the Cell Cycle
por: Klevecz, Robert R.
Publicado: (1969)

Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage
por: Deng, Haibin, et al.
Publicado: (2022)

Drug Targets for Cell Cycle Dysregulators in Leukemogenesis: In Silico Docking Studies
por: Jayaraman, Archana, et al.
Publicado: (2014)

Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T‐cell acute lymphoblastic leukemia
por: Yu, Haizhi, et al.
Publicado: (2020)

Targeting a Rate-Promoting Vibration with an Allosteric Mediator in Lactate Dehydrogenase
por: Dzierlenga, Michael W., et al.
Publicado: (2016)

HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP‐43 proteinopathies
por: Wu, Cheng‐Chun, et al.
Publicado: (2020)

Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
por: Philipp, Alexander B, et al.
Publicado: (2014)

MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A
por: Yuan, Daozhang, et al.
Publicado: (2017)

Targeted gene knockdown validates the essential role of lactate dehydrogenase in Cryptosporidium parvum
por: Witola, William H., et al.
Publicado: (2017)

Lactate Dehydrogenase as a Potential Therapeutic Drug Target to Control Babesia bigemina
por: He, Lan, et al.
Publicado: (2022)

Lactate Dehydrogenase A or B Knockdown Reduces Lactate Production and Inhibits Breast Cancer Cell Motility in vitro
por: Khajah, Maitham A., et al.
Publicado: (2021)

DUBbing Cancer: Deubiquitylating Enzymes Involved in Epigenetics, DNA Damage and the Cell Cycle As Therapeutic Targets
por: Pinto-Fernandez, Adan, et al.
Publicado: (2016)

H-2-controlled suppression of T cell response to lactate dehydrogenase B. Characterization of the lactate dehydrogenase B suppressor pathway
Publicado: (1982)

Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
por: Vella, Serena, et al.
Publicado: (2016)

Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy
por: Feng, Yangbo, et al.
Publicado: (2018)

Natural products targeting human lactate dehydrogenases for cancer therapy: A mini review
por: Yao, Huankai, et al.
Publicado: (2022)

The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapy
por: Bedognetti, Davide, et al.
Publicado: (2017)

Pyruvate Dehydrogenase and Tricarboxylic Acid Cycle Enzymes Are Sensitive Targets of Traumatic Brain Injury Induced Metabolic Derangement
por: Lazzarino, Giacomo, et al.
Publicado: (2019)

Monoclonal suppressor factor specific for lactate dehydrogenase B. I. Mechanism of interaction between the factor and its target cells
Publicado: (1983)

Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench
por: Yang, Yang, et al.
Publicado: (2021)

Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil
por: Han, Jung Ho, et al.
Publicado: (2021)

DNA damage and cell cycle events implicate cerebellar dentate nucleus neurons as targets of Alzheimer's disease
por: Chen, Jianmin, et al.
Publicado: (2010)

Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation
por: Silina, Linda, et al.
Publicado: (2022)

Human papillomaviruses sensitize cells to DNA damage induced apoptosis by targeting the innate immune sensor cGAS
por: Gusho, Elona, et al.
Publicado: (2022)

Lactate Dehydrogenase-Elevating Virus
por: Coutelier, Jean-Paul, et al.
Publicado: (2007)

Lactate Dehydrogenase: The Beacon of Hope?
por: Pandarathodiyil, Anitha Krishnan, et al.
Publicado: (2022)

Altered expression of lactate dehydrogenase and monocarboxylate transporter involved in lactate metabolism in broiler wooden breast
por: Zhao, Dan, et al.
Publicado: (2019)

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015)

Targeting the epigenetics of the DNA damage response in breast cancer
por: Montenegro, M F, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_culcbu39t05lk40kb74d7310l5